Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot study of raltegravir + darunavir/ritonavir + etravirine in multidrug-resistant HIV-1 with virologic failure
2007-000670-23Phase 2Completed
- Sponsor
- ANRS
- Start
- Mar 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of raltegravir, darunavir, ritonavir and etravirine in Human immunodeficiency virus infection type 1, sponsored by ANRS. Primary endpoint: Virologic response at week 24. Started Mar 2007; status: completed.
02
Drugs
raltegravirdarunavirritonaviretravirine
03
Conditions
Human immunodeficiency virus infection type 1
Beyond the preview
Go deeper on 2007-000670-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-000670-23.